Vaxart, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.33 | $0.01 | -$0.14 |
Q2 2024 | 1 | -$0.35 | $0.01 | -$0.15 |
Q3 2024 | 1 | -$0.24 | $0.00 | -$0.10 |
Q4 2024 | 3 | -$0.03 | $0.05 | -$0.00 |
Q1 2025 | 1 | -$0.38 | $0.01 | -$0.16 |
Q2 2025 | 1 | -$0.31 | $0.01 | -$0.13 |
Q3 2025 | 1 | -$0.26 | $0.00 | -$0.11 |
Q4 2025 | 1 | -$0.33 | $0.01 | -$0.14 |
Vaxart, Inc. Earnings Date And Information
Vaxart, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.09 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02667 by $0.06333. The company had revenue of 4.93 M for the quarter and had revenue of 7.38 M for the year. Vaxart, Inc. has generated $-1 earnings per share over the last year ($-0.57 diluted earnings per share) and currently has a price-to-earnings ratio of -1.89. Vaxart, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Vaxart, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/13/2024 | Q3 2024 | -$0.06 | $1.93 M | $4.93 M | ||
08/08/2024 | Q2 2024 | -$0.03 | -$0.09 | -0.06 | $100,000 | $6.40 M |
05/13/2024 | Q1 2024 | -$0.16 | -$0.14 | 0.02 | $2.18 M | |
03/14/2024 | Q4 2023 | -$0.15 | -$0.11 | 0.04 | $3.25 M | |
11/02/2023 | Q3 2023 | -$0.18 | -$0.11 | 0.07 | $100,000 | $446,000 |
08/03/2023 | Q2 2023 | -$0.19 | -$0.16 | 0.03 | $83,333 | $1.36 M |
05/04/2023 | Q1 2023 | -$0.19 | -$0.19 | 0 | $675,000 | |
03/15/2023 | Q4 2022 | -$0.22 | -$0.18 | 0.04 | $22,000 | |
11/08/2022 | Q3 2022 | -$0.23 | $50,000 | $0 | ||
08/08/2022 | Q2 2022 | -$0.21 | -$0.23 | -0.02 | $96,750 | $0 |
05/09/2022 | Q1 2022 | -$0.17 | -$0.20 | -0.03 | $85,000 | |
02/24/2022 | Q4 2021 | -$0.17 | -$0.17 | 0 | $74,000 | |
11/04/2021 | Q3 2021 | -$0.15 | -$0.14 | 0.01 | $118,400 | $200,000 |
08/05/2021 | Q2 2021 | -$0.14 | -$0.13 | 0.01 | $549,250 | $112,000 |
05/06/2021 | Q1 2021 | -$0.14 | $506,000 | |||
02/25/2021 | Q4 2020 | -$0.08 | -$0.13 | -0.05 | $356,000 | |
11/12/2020 | Q3 2020 | -$0.09 | -$0.08 | 0.01 | $1.07 M | $265,000 |
08/06/2020 | Q2 2020 | -$0.07 | -$0.12 | -0.05 | $1.27 M | $523,000 |
05/12/2020 | Q1 2020 | -$0.01 | -$0.02 | -0.01 | $2.90 M | |
03/19/2020 | Q4 2019 | -$0.13 | -$0.13 | 0 | $3.92 M |
Vaxart, Inc. Earnings: Frequently Asked Questions
-
When is Vaxart, Inc.'s earnings date?
Vaxart, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
How can I listen to Vaxart, Inc.'s earnings conference call?
The conference call for Vaxart, Inc.'s latest earnings report can be listened to online.
-
How can I read Vaxart, Inc.'s conference call transcript?
The conference call transcript for Vaxart, Inc.'s latest earnings report can be read online.
-
How much revenue does Vaxart, Inc. generate each year?
Vaxart, Inc. (:VXRT) has a recorded annual revenue of $7.38 M.
-
How much profit does Vaxart, Inc. generate each year?
Vaxart, Inc. (:VXRT) has a recorded net income of $7.38 M. Vaxart, Inc. has generated $-0.57 earnings per share over the last four quarters.
-
What is Vaxart, Inc.'s price-to-earnings ratio?
Vaxart, Inc. (:VXRT) has a price-to-earnings ratio of -1.89 and price/earnings-to-growth ratio is -0.17.